ゆうゆうと
liked
$Gyre Therapeutics(GYRE.US$
I don't think the parent company would go out of their way to just post this Q&A...
do you want to smell the te◯ ke ◯?
gnipharma.com/ i...
I don't think the parent company would go out of their way to just post this Q&A...
do you want to smell the te◯ ke ◯?
gnipharma.com/ i...
Translated
14
ゆうゆうと
commented on
$Gyre Therapeutics(GYRE.US$
If the Blue Eyes and the others join the race
That's probably not the ratio 🚀
Will a mega partnership finally come ⁉️🚀🚀🚀
Please wait until payday 💦
If the Blue Eyes and the others join the race
That's probably not the ratio 🚀
Will a mega partnership finally come ⁉️🚀🚀🚀
Please wait until payday 💦
Translated
7
3
ゆうゆうと
commented on
$Gyre Therapeutics(GYRE.US$
When will the disclosure approved for sale be issued? 💧
Somehow I want them to stop the sluggish days seem to come back again... (･_･;
When will the disclosure approved for sale be issued? 💧
Somehow I want them to stop the sluggish days seem to come back again... (･_･;
Translated
5
5
ゆうゆうと
liked and commented on
$Gyre Therapeutics(GYRE.US$
年末までにIND申請予定ゆえ、あるとすれば秋頃までに提携と踏んでますー🚀
6/28のラッセル入り以降は毎日ソワソワカウントダウンしときます笑
このまま出来高なく低空飛行が続くなら微足しし続けますー (´ω｀)
年末までにIND申請予定ゆえ、あるとすれば秋頃までに提携と踏んでますー🚀
6/28のラッセル入り以降は毎日ソワソワカウントダウンしときます笑
このまま出来高なく低空飛行が続くなら微足しし続けますー (´ω｀)
10
3
I just can't add it. I can't use bonuses without permission either 
I was still able to jump in if I was single 
$Gyre Therapeutics(GYRE.US$
親が動き始めたのでこっちもそろそろ着火かな😚それともまた今晩も🥲？とにかく待ちますいつまでも😗
親が動き始めたのでこっちもそろそろ着火かな😚それともまた今晩も🥲？とにかく待ちますいつまでも😗
8
3
ゆうゆうと
liked
$Gyre Therapeutics(GYRE.US$ A few percent each day is fine, like now, so it would be nice if the increase continued in increments.
Translated
11
ゆうゆうと
liked
$Gyre Therapeutics(GYRE.US$ There's little spare capacity, so I've added a little bit, but I never thought I could buy it for around $10 😅 It's getting close to the acquisition unit price of the old Nisa 💧 Needless to say, it's about half of the acquisition unit price of the specific or new Nisa 😢
To be honest, I'm happy to add it at a low price.
However, I'm sad about the extra power situation where I can't buy a lot... 😓
I'm going to dispose of 89 Bio a little bit and add Jaiko 😂
To be honest, I'm happy to add it at a low price.
However, I'm sad about the extra power situation where I can't buy a lot... 😓
I'm going to dispose of 89 Bio a little bit and add Jaiko 😂
Translated
11
1
ゆうゆうと
commented on
$Gyre Therapeutics(GYRE.US$Why are financial results announcements for the first quarter of 2024 falling even though they were insanely good? Is it bad if the parent GNI's financial results are not announced? It seems that parents are also restraining stock price manipulation by institutions, but there are also rumors that they are buzz around. They say it's better to go to Prime, but I guess they're still asking for 351.
Translated
14
2
ゆうゆうと
commented on
$Gyre Therapeutics(GYRE.US$
Since it's a license agreement for GYRE's subsidiary, I'd like GYRE to IR too...
Company News - Beijing Cantini Pharmaceutical Co., Ltd.
Since it's a license agreement for GYRE's subsidiary, I'd like GYRE to IR too...
Company News - Beijing Cantini Pharmaceutical Co., Ltd.
Translated
9
2
$Gyre Therapeutics(GYRE.US$ Is it the usual big shareholder ditch sale again?
Translated
8
![[empty]](https://static.moomoo.com/node_futunn_nnq/assets/images/folder.5c37692712.png)
![[error]](https://static.moomoo.com/node_futunn_nnq/assets/images/no-network.991ae8055c.png)
![[loading]](data:image/svg+xml;base64,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)